Lidocaine

Content
Download/Print

Definition

Lidocaine is a local anesthetic from the amide group and is widely used in both human and veterinary medicine. It is primarily used for local pain control in minor procedures, as an antiarrhythmic for cardiac arrhythmia, and as ointments and gels for topical anesthesia. The active ingredient blocks voltage-gated sodium channels in cell membranes, inhibiting the conduction of nerve impulses. This property makes lidocaine an effective pain reliever, but overdose or improper use poses significant risks for small animals.

Lidocaine toxicity differs significantly between animal species. Cats are particularly sensitive due to their limited capacity for glucuronidation—an important metabolic pathway for breaking down medications in the liver. While dogs have somewhat higher tolerance, even small overdoses can cause severe signs of poisoning in them as well. The therapeutic window—the gap between an effective and a toxic dose—is relatively narrow in both species.

The most important facts at a glance

Lidocaine poisoning is a relevant toxicological problem in small animal medicine and can result from both medical use and accidental exposure. The active ingredient blocks sodium channels, thereby impairing impulse conduction in nerve and heart muscle cells. Cats in particular are at risk due to their limited metabolism.

Clinical signs primarily affect the nervous system with symptoms such as restlessness, tremor and convulsions, and the cardiovascular system in the form of arrhythmia and blood pressure changes. Diagnosis is based mainly on the medical history and the characteristic symptom pattern, supported by electrocardiogram examinations.

Therapy includes decontamination measures, symptomatic treatment of neurological and cardiovascular symptoms, and supportive measures. Intravenous lipid therapy has proven to be a promising treatment option in severe intoxication / poisoning.

With early recognition and appropriate treatment, the prognosis is favorable, although recovery time in cats may be longer due to their delayed metabolism. Follow-up care focuses on monitoring possible long-term effects and prevention of renewed exposure.

For veterinarians and pet owners, it is important to know the risks of lidocaine and to take species-specific differences into account when using it. Careful dosing and safe storage of lidocaine-containing products are crucial to prevent poisoning cases.

Causes, development and progression

Lidocaine increases the excitation threshold in nerve cells and slows impulse conduction.
In the heart muscle, lidocaine reduces excitability, the speed of impulse conduction and contractile force, thereby lowering the risk of arrhythmia.

Lidocaine poisoning in pets mainly arises from three scenarios: iatrogenic overdose during veterinary treatment, accidental oral ingestion of lidocaine-containing products, or improper use by pet owners.

In iatrogenic poisoning, excessively high doses, overly rapid intravenous administration, or unintended intravascular injection during what was meant to be subcutaneous use can lead to toxic plasma levels. Animals with impaired liver or kidney function are particularly at risk, as metabolism and excretion of the active ingredient may be delayed.

Accidental oral ingestion usually occurs when animals gain access to the owner’s medications. Although orally ingested lidocaine is subject to a significant first-pass effect in the liver, toxic plasma levels can still occur if larger amounts are ingested. In cats, this effect is even more pronounced due to their metabolic characteristics.

Another common cause is improper use by pet owners who apply human lidocaine products to their pets. The concentration of these products is often unsuitable for animals, and the dose is frequently calculated incorrectly. Combination products are particularly dangerous because, in addition to lidocaine, they may contain other active ingredients that can be toxic to animals.

Mechanism of action

Lidocaine is absorbed after oral ingestion. It is also dangerous because cats have limited ability to break it down.
The toxic effects of lidocaine initially affect the central nervous system (CNS). The CNS is more sensitive and reacts at lower lidocaine plasma levels than, for example, the cardiovascular system.
However, for the potentially fatal outcome of lidocaine intoxication / poisoning, the effects on the cardiovascular system are more important.
Slowed impulse conduction in the heart, up to conduction blocks, leads to pronounced cardiac arrhythmia and ultimately cardiac arrest.
In cats, a genetically limited ability to metabolize it in the liver leads to persistently high plasma levels during intoxication / poisoning.

Supplements

Toxicity mainly affects the CNS (central nervous system) and the cardiovascular system.

1. Principle of Lidocaine Action (Physiological and Toxicological)

Lidocaine selectively blocks voltage-gated sodium channels (Na⁺ channels) in neuronal and cardiac cell membranes. This inhibits the conduction of action potentials in nerves and heart muscle cells.

A) in the Therapeutic Range:

  • Inhibition of Na⁺ channels leads to reversible interruption of nerve conduction → local pain relief.
  • In the heart: Shortening of action potential duration → treatment of ventricular tachyarrhythmias.

b) In the toxic range:

  • Lidocaine also inhibits central and cardiac sodium channels.
  • This causes excessive inhibition of neuronal excitation conduction and cardiac impulse conduction, leading to severe neurological and cardiovascular symptoms.

2. Pathophysiology of lidocaine poisoning

Central nervous system – first target of toxicity

  • Initial phase: Reversible blockade of inhibitory interneurons → excess excitation, e.g., restlessness, muscle tremors, ataxia.
  • Advanced phase: Generalized Na⁺ channel blockade → depression of overall neuronal activity → lethargy, seizures, coma.

Cardiovascular System

  • Blockade of cardiac Na⁺ channels → delayed impulse conduction, prolonged depolarization.
  • Result: bradycardia, AV block, hypotension, ventricular arrhythmias, and in extreme cases ventricular fibrillation or cardiac arrest.
  • Myocardial contractility can also be depressed by lidocaine → risk of cardiogenic shock.

Further Effects

  • Vasodilation due to influence on smooth vascular musculature → blood pressure drop.
  • At high doses: metabolic acidosis, respiratory depression

3. Species Differences and Risk Factors

Dog:

  • Generally better tolerated than cats.
  • Toxic dose i.v.: approximately >20 mg/kg.
  • Symptoms often appear rapidly after intravenous or intravascular administration.

Cat:

  • Very sensitive to lidocaine because hepatic metabolism (especially glucuronidation) is limited.
  • Toxic dose i.v.: as low as 6–10 mg/kg.
  • Oral use is particularly dangerous (e.g., in the mouth): leads to severe CNS disorders, hypersalivation, collapse.

4. Clinical Symptoms of Lidocaine Poisoning

Organ System Symptoms
CNS (central nervous system) Restlessness, muscle tremors, ataxia, seizures, coma
Cardiovascular Bradycardia, hypotension, arrhythmia, AV block, cardiac arrest
Respiration Shortness of breath, hypoventilation, cyanosis
General Weakness, hypersalivation, hyperthermia due to muscle activity

5. Mechanistic Summary

Target Structure Mechanism Consequence
Voltage-gated Na⁺ channels Blockade of fast sodium channels Inhibition of impulse conduction in nerves and myocardium
Interneurons in the CNS (central nervous system) Disinhibition due to early blockade → later total inhibition Seizures, CNS depression, respiratory arrest
Heart muscle Delayed spread of excitation → reduced contraction Bradycardia, hypotension, arrhythmia
Smooth vascular musculature Vasodilation Blood pressure drop, circulatory failure

 

6. Conclusion

Lidocaine poisoning in dogs and cats results from systemic overdose and mainly affects the CNS (central nervous system) and the cardiovascular system. The underlying mechanism is the blockade of voltage-gated sodium channels, which massively disrupts the electrical excitability of nerve cells and cardiomyocytes. While dogs show moderate tolerance, cats are extremely sensitive, especially with oral or intravenous exposure. Lidocaine poisoning is a veterinary emergency and requires immediate symptomatic treatment, especially in cases of convulsions or circulatory weakness.

Symptoms of intoxication

Regarding the nervous system

  • Confusion
  • Restlessness
  • Tremors and
  • Convulsions (tonic-clonic)

Regarding the cardiovascular system

  • Initially increased heart rate and blood pressure
  • Later decrease in heart rate and blood pressure
  • Cardiac arrhythmias
  • Ventricular fibrillation
  • Cardiac arrest (asystole)
  • Coma
  • Respiratory Arrest

The clinical signs of lidocaine poisoning primarily affect the nervous system and the cardiovascular system, with neurological symptoms usually appearing first. Symptoms usually develop rapidly after exposure and can vary in severity depending on the degree of intoxication / poisoning.

In the CNS (central nervous system), affected animals initially show restlessness, disorientation and confusion. As plasma levels rise, muscle tremors (tremor), ataxia and coordination disorders may occur. In severe cases, tonic-clonic convulsions develop, which can progress to coma. These neurological symptoms result from blockade of inhibitory neurons in the CNS (central nervous system), leading to overactivity of excitatory systems.

Cardiovascular effects typically begin with initial tachycardia and hypertension, followed by progressive bradycardia and hypotension with ongoing exposure. By blocking sodium channels in the heart muscle, disturbances in impulse conduction occur, which can manifest as various arrhythmias. In severe cases, ventricular fibrillation and ultimately cardiac arrest can occur. These cardiovascular effects are particularly dangerous because they can persist even after the neurological symptoms have subsided.

In cats, symptoms may last longer and be more severe due to delayed breakdown of lidocaine. In addition, gastrointestinal symptoms such as vomiting and drooling may occur, especially after oral ingestion of the active ingredient.

Diagnosis

Diagnosis of lidocaine poisoning is based primarily on the medical history, clinical signs, and ruling out other causes. A thorough discussion with the owner is crucial to obtain information about possible sources of exposure, timing of exposure, and the estimated amount ingested.

The clinical exam includes a full neurological evaluation and cardiovascular assessment. Particular attention is paid to heart rate, heart rhythm, and blood pressure. An electrocardiogram is an important diagnostic tool because lidocaine can cause characteristic changes, including sinus bradycardia, prolonged PR intervals, widened QRS complexes, and various forms of heart block.

Laboratory tests mainly serve to rule out other causes and assess organ function. A complete blood count, serum electrolytes, kidney values and liver values should be measured to assess the patient’s overall condition and detect possible complications. Direct measurement of lidocaine plasma levels is rarely available in veterinary practice and is often not timely enough for acute treatment.

Differential diagnoses include other poisonings (especially from other local anesthetics, antiarrhythmics, or CNS-active substances), metabolic disorders, primary neurological diseases, and primary cardiac arrhythmias. The temporal correlation between exposure and onset of symptoms, the characteristic pattern of clinical signs, and the response to therapy support the diagnosis.

Therapeutic principles

After oral ingestion of lidocaine, decontamination by inducing vomiting, administering activated charcoal and/or intestinal lavage depends on the time that has passed between ingestion of lidocaine and presentation to the veterinarian.
There is no antidote.
Therapy is symptomatic.
In the event of cardiac arrest, immediate resuscitation is required.
Because cats break down lidocaine more slowly, cardiovascular monitoring needs to be extended and repeated resuscitation may be necessary.
In human medicine, intravenous lipids are administered immediately after successful resuscitation.
The effect of a lipid infusion is explained by the binding of fat-soluble lidocaine molecules to the infused lipids.
Seizures and tremor are controlled with medication so that symptoms are relieved as much as possible, but deep anesthesia is not the goal. By repeatedly giving smaller individual doses and combining several medications, the dose of anticonvulsants can be reduced and the risk of side effects minimized.

Supplements

Treating lidocaine poisoning requires a fast, structured approach. Since there is no specific antidote, therapy is based on three pillars: decontamination, symptomatic treatment, and supportive measures.

If oral ingestion was recent, decontamination can be performed by inducing vomiting (only in an alert animal and within the first 1–2 hours) and administering activated charcoal (1–4 g/kg body weight). With dermal exposure, the affected area should be thoroughly rinsed with lukewarm water to remove any remaining lidocaine.

Symptomatic therapy is guided by the predominant clinical signs. For convulsions, anticonvulsants such as diazepam (0.5–2 mg/kg IV) or phenobarbital (2–6 mg/kg IV) are used. It is important to titrate the dose to avoid excessive respiratory depression. For cardiovascular complications, specific antiarrhythmics may be indicated depending on the type of arrhythmia. For bradycardia, atropine (0.02–0.04 mg/kg IV) can be administered, while hypotension is treated with fluid therapy and, if needed, vasopressors.

A promising therapy option for severe lidocaine poisoning is intravenous lipid infusion (Lipid Rescue Therapy). This treatment is based on the principle that lipophilic substances such as lidocaine can be bound in a lipid emulsion, reducing their plasma concentration and thus their toxic effect. The protocol typically includes an initial bolus of 20% lipid emulsion (1.5 ml/kg over 1–2 minutes), followed by a continuous infusion (0.25 ml/kg/min for 30–60 minutes).

Supportive measures include fluid therapy to promote renal elimination, oxygen supplementation in hypoxia, and in severe cases possibly mechanical ventilation. Continuous monitoring of vital signs, especially heart function, is essential in order to respond quickly to changes.

Prognosis & follow-up care

The prognosis is good.

With early recognition and appropriate treatment, the prognosis for lidocaine poisoning is generally favorable. The course and chances of recovery depend largely on the amount ingested, the time to start of therapy, and the animal’s individual health status.

With mild to moderate poisoning, complete recovery without long-term effects is usually expected after successful treatment. Neurological symptoms usually resolve within 24 hours, while cardiovascular effects may persist somewhat longer. In cats, the recovery phase may be prolonged due to their delayed metabolism.

Severe intoxication / poisoning with prolonged convulsions or serious cardiac arrhythmia can potentially lead to permanent neurological damage or myocardial impairment. In such cases, close follow-up with regular cardiology and neurological check-ups is indicated.

Follow-up initially includes inpatient monitoring for at least 24–48 hours after the acute symptoms have subsided, especially in cats. After discharge, owners should watch for possible relapses or delayed-onset symptoms. These include subtle neurological abnormalities such as changes in behavior, coordination disorders or weakness, as well as signs of heart problems such as reduced performance, cough or shortness of breath.

Preventive measures to avoid re-exposure are an essential part of follow-up care. These include safely storing medications out of pets’ reach and educating owners about the risks of self-medicating their animals with human products.

Research outlook

Research into lidocaine toxicity in small animals is continuously evolving, with several promising approaches being pursued. One focus is on optimizing Lipid Rescue Therapy, which has been increasingly adopted in veterinary practice in recent years. Current studies are investigating the optimal dosage, administration rate, and composition of lipid emulsions for different animal species and degrees of poisoning.

Another area of research involves developing specific biomarkers for early detection of local anesthetic-induced toxicities. These could help identify at-risk patients early and initiate preventive measures. In parallel, new lidocaine formulations with improved pharmacokinetic properties and lower toxicity potential are being researched, tailored specifically to the needs of different animal species.

Special attention is also being paid to genetic factors that influence individual sensitivity to lidocaine. By identifying genetic polymorphisms associated with an increased risk of poisoning, personalized dosing regimens could be developed in the future to minimize toxicity risk.

Integrating point-of-care tests for rapid measurement of lidocaine plasma levels in veterinary practice could improve diagnostic certainty and enable more targeted therapy. Such rapid tests are currently in development and may become available in the coming years.

Last but not least, research is also focusing on the long-term prognosis after surviving lidocaine poisoning. Longitudinal studies are examining possible subtle neurological or cardiac sequelae and their impact on the affected animals’ quality of life.

Frequently asked questions (FAQs)

  1. How quickly do the symptoms of lidocaine poisoning appear?

Symptoms of lidocaine poisoning can occur very quickly. With intravenous administration, the first signs are often seen within minutes, while with oral ingestion it typically takes 30–60 minutes. In cats, symptoms can last longer due to delayed breakdown.

  1. Can I apply human lidocaine ointment to my pet for minor injuries?

No, using human lidocaine products on pets without veterinary instructions is not recommended. The concentration is often unsuitable for animals, and there is a risk of overdose from ingestion through licking. Always consult a veterinarian about suitable treatment options.

  1. Which animals are particularly sensitive to lidocaine?

Cats are particularly sensitive to lidocaine due to their limited metabolism. Small dog breeds, young animals, and animals with liver or kidney disease also have an increased risk of poisoning.

  1. How is lidocaine poisoning treated?

Treatment includes decontamination measures (if possible), symptomatic therapy for neurological and cardiovascular symptoms, intravenous fluid therapy, and in severe cases intravenous lipid therapy. Inpatient monitoring is usually necessary.

  1. Is there an antidote for lidocaine poisoning?

There is no specific antidote for lidocaine. Treatment aims to control symptoms and support the body in elimination of the active ingredient. Intravenous lipid therapy can help bind lidocaine in the bloodstream and reduce its toxic effects.

  1. Can my pet fully recover after lidocaine poisoning?

With early recognition and appropriate treatment, the prognosis for a full recovery is good. However, severe poisoning with prolonged convulsions or cardiac arrhythmia can lead to permanent damage.

  1. How can I prevent lidocaine poisoning in my pet?

Store all medications securely out of pets’ reach. Use lidocaine products only as directed by a veterinarian and at the prescribed dose. Make sure your pet cannot lick treated skin areas.

  1. What alternative pain relievers are safer for pets than lidocaine?

For pain management in pets, there are various veterinary-approved medications available, including non-steroidal anti-inflammatory drugs (NSAIDs) such as meloxicam or carprofen, as well as opioids. The choice of a suitable pain reliever should always be made in consultation with the veterinarian.

  1. How long does it take for lidocaine to be metabolized by my pet’s body?

The elimination half-life of lidocaine is about 1–2 hours in dogs; in cats it can be significantly longer due to limited metabolism (up to 4–6 hours). Complete elimination usually takes about 4 to 5 times the half-life.

  1. Can lidocaine poisoning be fatal?

Yes, untreated severe lidocaine poisoning can lead to death due to cardiac arrhythmia, respiratory paralysis or convulsions. With early recognition and appropriate treatment, however, the risk is significantly reduced.

Literature

  • Stehr, S., & Christ, T. (2017). Local anesthetics and lipid rescue. In Practice of Anesthesiology (pp. 445–456). Springer, Berlin, Heidelberg.
  • Fernandez, A. L., Lee, J. A., Rahilly, L., Hovda, L., Brutlag, A. G., & Engebretsen, K. (2021). The use of intravenous lipid emulsion as an antidote in veterinary toxicology. Journal of Veterinary Emergency and Critical Care, 31(2), 173–188.
  • Kaplan, A., & Whelan, M. (2022). Lidocaine toxicity in small animals: Clinical manifestations, diagnosis, and current treatment recommendations. Veterinary Clinics of North America: Small Animal Practice, 52(3), 703–718.
  • Martin-Flores, M., & Campoy, L. (2019). Local and regional anaesthetic techniques for small animals: A review of current literature and clinical applications. The Veterinary Journal, 246, 55–65.
  • Posner, L. P., & Burns, P. (2021). Update on local anesthetic toxicity in veterinary patients. Veterinary Clinics of North America: Small Animal Practice, 51(4), 945–963.
  • Sanchis-Mora, S., & Pelligand, L. (2020). Pharmacokinetic and pharmacodynamic considerations for the use of local anaesthetics in small animals. The Veterinary Journal, 260, 105464.
  • Löwe G, Löwe O. Poisonings in Dogs and Cats – A Veterinary Guide. 2nd Edition. Kreuztal: Kynos-Verlag. 2021; 208 p.